SELLAS Life Sciences Group, Inc. Share Price
SLSSELLAS Life Sciences Group, Inc. Stock Performance
Open $1.89 | Prev. Close $1.90 | Circuit Range N/A |
Day Range $1.83 - $1.89 | Year Range $0.77 - $2.27 | Volume 58,756 |
Average Traded $1.85 |
SELLAS Life Sciences Group, Inc. Share Price Chart
About SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
SELLAS Life Sciences Group, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Sep-25 | $1.89 | $1.85 | +0.00% |
09-Sep-25 | $1.89 | $1.85 | -1.85% |
08-Sep-25 | $1.95 | $1.89 | -0.79% |
05-Sep-25 | $1.80 | $1.91 | +6.72% |
04-Sep-25 | $1.78 | $1.78 | +0.28% |
03-Sep-25 | $1.83 | $1.78 | -2.47% |
02-Sep-25 | $1.91 | $1.82 | -4.70% |
FAQs on SELLAS Life Sciences Group, Inc. Share Price
Can I buy SELLAS Life Sciences Group, Inc. shares in India?
What is the share price of SELLAS Life Sciences Group, Inc.?
What is the 5 year returns of SELLAS Life Sciences Group, Inc.?
What are the high & low stock price of SELLAS Life Sciences Group, Inc. today?
What is the 52-week high and low of SELLAS Life Sciences Group, Inc. stock?